About R Gregory Brophy
Form D filings for NKore Biotherapeutics in 2023 list R Gregory Brophy as chief executive officer and director.
R Gregory Brophy first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name R Gregory Brophy in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people R Gregory Brophy works with at each company, as listed on that company's latest Form D.
NKore Biotherapeutics, LLC · Form D, Apr 13, 2023